Cardinal Health (NYSE:CAH) Given New $237.00 Price Target at Wells Fargo & Company

Cardinal Health (NYSE:CAH) had its price target boosted by Wells Fargo & Company from $221.00 to $237.00 in a research report released on Thursday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock.

Several other brokerages also recently commented on CAH. TD Cowen lifted their target price on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. UBS Group boosted their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Mizuho set a $222.00 price objective on Cardinal Health in a report on Monday. Barclays began coverage on shares of Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 target price on the stock. Finally, Jefferies Financial Group set a $220.00 price target on Cardinal Health and gave the stock a “buy” rating in a research report on Monday, November 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $216.33.

Cardinal Health Trading Down 0.1%

CAH stock opened at $213.25 on Thursday. Cardinal Health has a 1-year low of $120.72 and a 1-year high of $215.48. The business’s 50 day simple moving average is $205.19 and its 200 day simple moving average is $174.32. The firm has a market capitalization of $50.67 billion, a PE ratio of 32.16, a PEG ratio of 1.52 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter last year, the firm posted $1.88 EPS. The company’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts predict that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Institutional Investors Weigh In On Cardinal Health

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the fourth quarter worth approximately $25,000. SJS Investment Consulting Inc. raised its holdings in Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Atlantic Edge Private Wealth Management LLC lifted its position in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. Barnes Dennig Private Wealth Management LLC boosted its stake in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after purchasing an additional 53 shares during the last quarter. Finally, JPL Wealth Management LLC acquired a new stake in shares of Cardinal Health during the third quarter worth $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.